Clinical Trials – Collective effort to redefine recession
Clinical Trials is basically a huge process accompanies by a set of procedures which needs to be followed with utmost precise and perfection. The basic nature of clinical investigations is cost and time involved. This is always a challenge that Clinical Research companies and sponsors face. However due to efficient clinical budgeting, planning and protocol preparation complex situations are avoided.
In the time when everything goes wrong across the globe, in an era that has stamped its impact on every sector across the world, an industry particularly the clinical trials or clinical research industry which is also dependant on many other parameters faces severe pressure. The great old theory of Darwin “Survival of the fittest” comes into play during the tough times.
Though recession has shown signs of frustration among the industry segments, clinical trials industry with its strong foundation and basics never showed any symbols of panic, however with the situation of recession going from bad to worst and with the big research companies predicting the actual worse is yet to come, Are clinical trials industry and companies globally ready to face it? What surviving strategies do the companies need to adopt. This requires a huge collective effort globally to fight it.
The news this hour that Charles River Laboratories reducing the workforce by 3% rings in the bells for others as well. Let’s initiate this collective effort to survive recession and be ready for the good days ahead. Lets join together to redefine the clinical trials destiny by sharing the experiences and strategies to fight recession.
Clinical Trials is basically a huge process accompanies by a set of procedures which needs to be followed with utmost precise and perfection. The basic nature of clinical investigations is cost and time involved. This is always a challenge that Clinical Research companies and sponsors face. However due to efficient clinical budgeting, planning and protocol preparation complex situations are avoided.
In the time when everything goes wrong across the globe, in an era that has stamped its impact on every sector across the world, an industry particularly the clinical trials or clinical research industry which is also dependant on many other parameters faces severe pressure. The great old theory of Darwin “Survival of the fittest” comes into play during the tough times.
Though recession has shown signs of frustration among the industry segments, clinical trials industry with its strong foundation and basics never showed any symbols of panic, however with the situation of recession going from bad to worst and with the big research companies predicting the actual worse is yet to come, Are clinical trials industry and companies globally ready to face it? What surviving strategies do the companies need to adopt. This requires a huge collective effort globally to fight it.
The news this hour that Charles River Laboratories reducing the workforce by 3% rings in the bells for others as well. Let’s initiate this collective effort to survive recession and be ready for the good days ahead. Lets join together to redefine the clinical trials destiny by sharing the experiences and strategies to fight recession.
Its a wonderful effort...I feel this is an opportunity to create a platform for the future instead of panic now. During this tough times its beneficial to reduce our focus on clinical activity and focus more on the clients. We should assure that we standby our clients in tough times, which paves way for a long term success.....Hope this counts...
ReplyDelete